VIM and gastric cancer: High levels of ZEB2 have previously been reported to promote epithelial-mesenchymal transition (EMT) of gastric cancer cells via regulation of expression of CDH1 (E-cadherin) and other EMT markers, such as VIM (vimentin) and matrix metallopeptidases (MMP2 and MMP9) [99].